Dogwood Therapeutics, Inc. financial data

Symbol
DWTX on Nasdaq
Location
Alpharetta, GA
Fiscal year end
31 December
Latest financial report
10-Q - Q3 2025 - 07 Nov 2025

Key Ratios

Label TTM Value / Value Unit Change %
Current Ratio 606% % 26%
Debt-to-equity 658% % 2412%
Return On Equity -1377% % -534%
Return On Assets -40% % 77%

Shares

Label TTM Value / Value Unit Change %
Entity Common Stock, Shares Outstanding 2,293,162 shares 72%
Common Stock, Shares, Outstanding 2,293,162 shares 107%
Entity Public Float $5,755,555 USD -76%
Common Stock, Value, Issued $229 USD 106%
Weighted Average Number of Shares Outstanding, Basic 1,919,433 shares 73%
Weighted Average Number of Shares Outstanding, Diluted 1,919,433 shares 73%

Income Statement

Label TTM Value / Value Unit Change %
Research and Development Expense $21,844,233 USD 1343%
General and Administrative Expense $9,860,084 USD 129%
Operating Income (Loss) $31,704,317 USD -444%
Income (Loss) from Continuing Operations before Income Taxes, Noncontrolling Interest $38,016,041 USD -564%
Net Income (Loss) Attributable to Parent $38,204,793 USD -567%
Earnings Per Share, Basic -26 USD/shares -159%
Earnings Per Share, Diluted -26 USD/shares -159%

Balance Sheet

Label TTM Value / Value Unit Change %
Cash and Cash Equivalents, at Carrying Value $10,126,710 USD 396%
Assets, Current $11,655,377 USD 410%
Property, Plant and Equipment, Net $15,293 USD
Operating Lease, Right-of-Use Asset $174,008 USD
Intangible Assets, Net (Excluding Goodwill) $67,919,601 USD
Goodwill $12,209,591 USD
Assets $91,992,613 USD 3929%
Accounts Payable, Current $584,602 USD 28%
Employee-related Liabilities, Current $597,278 USD
Accrued Liabilities, Current $1,957,641 USD 123%
Liabilities, Current $2,596,809 USD 95%
Deferred Income Tax Liabilities, Net $11,890,483 USD
Operating Lease, Liability, Noncurrent $120,212 USD
Other Liabilities, Noncurrent $15,381,077 USD
Liabilities $14,607,504 USD 995%
Accumulated Other Comprehensive Income (Loss), Net of Tax $1,636,135 USD
Retained Earnings (Accumulated Deficit) $104,295,867 USD -58%
Stockholders' Equity Attributable to Parent $7,258,152 USD 664%
Liabilities and Equity $91,992,613 USD 3929%

Popular Metrics

Label TTM Value / Value Unit Change %
Net Cash Provided by (Used in) Operating Activities $4,682,554 USD -400%
Net Cash Provided by (Used in) Financing Activities $7,372,378 USD
Common Stock, Shares Authorized 43,000,000 shares 0%
Common Stock, Shares, Issued 2,300,880 shares 106%
Common Stock, Par or Stated Value Per Share 0 USD/shares 0%
Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents $10,126,710 USD 396%
Deferred Tax Assets, Valuation Allowance $31,370,027 USD 216%
Deferred Tax Assets, Gross $38,273,766 USD 277%
Operating Lease, Liability $174,778 USD
Depreciation $17,022 USD
Comprehensive Income (Loss), Net of Tax, Attributable to Parent $39,840,928 USD -650%
Lessee, Operating Lease, Liability, to be Paid $194,351 USD
Property, Plant and Equipment, Gross $19,005 USD
Operating Lease, Liability, Current $54,566 USD
Lessee, Operating Lease, Liability, to be Paid, Year Two $67,198 USD
Lessee, Operating Lease, Liability, to be Paid, Year One $66,026 USD
Operating Lease, Weighted Average Discount Rate, Percent 0.08 pure
Deferred Income Tax Expense (Benefit) $188,752 USD
Lessee, Operating Lease, Liability, Undiscounted Excess Amount $19,573 USD
Lessee, Operating Lease, Liability, to be Paid, Year Three $43,236 USD
Deferred Tax Assets, Operating Loss Carryforwards $26,081,361 USD 266%
Preferred Stock, Shares Issued 0 shares
Preferred Stock, Shares Authorized 1,997,786 shares -0.11%
Lessee, Operating Lease, Liability, to be Paid, Year Four $41,829 USD
Operating Lease, Payments $121,383 USD
Additional Paid in Capital $73,158,686 USD 8.6%
Preferred Stock, Shares Outstanding 0 shares
Deferred Tax Assets, Net of Valuation Allowance $6,903,739 USD 3102%
Preferred Stock, Par or Stated Value Per Share 0 USD/shares 0%